Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Genitourinary 1

Conditions

Prostatic Neoplasms 47Polycystic Ovary Syndrome 6Infertility 2Hyperandrogenism 2Stage I Prostate Adenocarcinoma AJCC v7 1Sexual Dysfunction, Physiological 1Prostatic Intraepithelial Neoplasia 1Prostate Adenocarcinoma 1Primary Dysautonomias 1Overweight 1Ovarian Neoplasms 1Oligomenorrhea 1Neoplasm Metastasis 1Metabolic Syndrome 1Kidney Diseases 1Insulin Resistance 1Hypertension 1Hirsutism 1Castration-resistant Prostate Cancer 1Carcinoma, Ovarian Epithelial 1Anovulation 1Amenorrhea 1Adenocarcinoma 1

Interventions

Psychiatric Rehabilitation 6Surveys and Questionnaires 5Counseling 4Therapeutics 3Radiotherapy 3Sildenafil Citrate 2High-Intensity Focused Ultrasound Ablation 2Exercise 2trametinib 1sotorasib 1selpercatinib 1pembrolizumab 1osimertinib 1methyl N-acetylsibirosaminide 1methyl 3-mercaptopropionimidate 1lorlatinib 1dabrafenib 1cemiplimab 1brigatinib 1bicalutamide 1alectinib 1Vitamin E 1Vitamin D 1Uterine Myomectomy 1Testosterone Propionate 1Testosterone 1Tadalafil 1Surgical Procedures, Operative 1Sexual Health 1Sex Education 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sexual Dysfunction, Physiological × Flutamide × Clear all
NCT00003323 2016-07-04

Hormone Therapy in Treating Patients With Prostate Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
101 enrolled
GenitourinaryOther

Infertility, Prostatic Neoplasms, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡